These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 37812889)
1. S100A8/A9: An emerging player in sepsis and sepsis-induced organ injury. Wang Q; Long G; Luo H; Zhu X; Han Y; Shang Y; Zhang D; Gong R Biomed Pharmacother; 2023 Dec; 168():115674. PubMed ID: 37812889 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction. Jakobsson G; Papareddy P; Andersson H; Mulholland M; Bhongir R; Ljungcrantz I; Engelbertsen D; Björkbacka H; Nilsson J; Manea A; Herwald H; Ruiz-Meana M; Rodríguez-Sinovas A; Chew M; Schiopu A Crit Care; 2023 Sep; 27(1):374. PubMed ID: 37773186 [TBL] [Abstract][Full Text] [Related]
3. [S100A8/A9 and periodontal inflammatory diseases]. Gao HY; Meng HX; Hou JX Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Sep; 55(9):679-684. PubMed ID: 32878406 [TBL] [Abstract][Full Text] [Related]
4. S100A8/A9 in Inflammation. Wang S; Song R; Wang Z; Jing Z; Wang S; Ma J Front Immunol; 2018; 9():1298. PubMed ID: 29942307 [TBL] [Abstract][Full Text] [Related]
5. Deficiency of S100A8/A9 attenuates pulmonary microvascular leakage in septic mice. Yu J; Zhao B; Pi Q; Zhou G; Cheng Z; Qu C; Wang X; Kong L; Luo S; Du D; Guo Y Respir Res; 2023 Nov; 24(1):288. PubMed ID: 37978525 [TBL] [Abstract][Full Text] [Related]
6. S100A8/A9: From basic science to clinical application. Pruenster M; Vogl T; Roth J; Sperandio M Pharmacol Ther; 2016 Nov; 167():120-131. PubMed ID: 27492899 [TBL] [Abstract][Full Text] [Related]
7. S100A8 and S100A9 in Cancer. Chen Y; Ouyang Y; Li Z; Wang X; Ma J Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188891. PubMed ID: 37001615 [TBL] [Abstract][Full Text] [Related]
8. Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus. Lood C; Stenström M; Tydén H; Gullstrand B; Källberg E; Leanderson T; Truedsson L; Sturfelt G; Ivars F; Bengtsson AA Arthritis Res Ther; 2011 Apr; 13(2):R60. PubMed ID: 21492422 [TBL] [Abstract][Full Text] [Related]
10. S100a8/a9 contributes to sepsis-induced cardiomyopathy by activating ERK1/2-Drp1-mediated mitochondrial fission and respiratory dysfunction. Wu F; Zhang YT; Teng F; Li HH; Guo SB Int Immunopharmacol; 2023 Feb; 115():109716. PubMed ID: 36652759 [TBL] [Abstract][Full Text] [Related]
11. S100A8/A9 in COVID-19 pathogenesis: Impact on clinical outcomes. Mellett L; Khader SA Cytokine Growth Factor Rev; 2022 Feb; 63():90-97. PubMed ID: 34728150 [TBL] [Abstract][Full Text] [Related]
12. Pathogenic roles of neutrophil-derived alarmins (S100A8/A9) in heart failure: From molecular mechanisms to therapeutic insights. Bai B; Xu Y; Chen H Br J Pharmacol; 2023 Mar; 180(5):573-588. PubMed ID: 36464854 [TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of S100A12 and S100A8/A9 (calprotectin) in dogs with sepsis or the systemic inflammatory response syndrome. Thames BE; Barr JW; Suchodolski JS; Steiner JM; Heilmann RM J Vet Diagn Invest; 2019 Jul; 31(4):645-651. PubMed ID: 31170888 [TBL] [Abstract][Full Text] [Related]
14. S100a8/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-Induced cardiac inflammation and injury. Wu Y; Li Y; Zhang C; A X; Wang Y; Cui W; Li H; Du J Hypertension; 2014 Jun; 63(6):1241-50. PubMed ID: 24711518 [TBL] [Abstract][Full Text] [Related]
15. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis. Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236 [TBL] [Abstract][Full Text] [Related]